Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product
- 23 December 1998
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 7 (3), 249-258
- https://doi.org/10.1016/s0928-0987(98)00034-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Assessment of Pharmaceutical Quality of Furosemide Tablets from Multinational MarketsDrug Development and Industrial Pharmacy, 1998
- Calibration—The USP Dissolution Apparatus Suitability TestDrug Information Journal, 1996
- Improved Hydrodynamics for USP Apparatus 2Dissolution Technologies, 1996
- Industry Perspective on Dissolution Apparatus CalibrationDissolution Technologies, 1995
- A Critical Assessment of the Usp Dissolution Apparatus Suitability Test CriteriaDrug Development and Industrial Pharmacy, 1995
- Evaluation of the Performance of Prednisone and Salicylic Acid Usp Dissolution CalibratorsDrug Development and Industrial Pharmacy, 1995
- Pharmaceutical Quality of Glibenclamide Products A Multinational Postmarket Comparative StudyDrug Development and Industrial Pharmacy, 1993
- The Development of USP Dissolution and Drug Release StandardsPharmaceutical Research, 1990
- Systematic Error Associated with Apparatus 2 of the USP Dissolution Test IV: Effect of Air Dissolved in the Dissolution MediumJournal of Pharmaceutical Sciences, 1983